| Revista: | Journal of technology management & innovation |
| Base de datos: | CLASE |
| Número de sistema: | 000408081 |
| ISSN: | 0718-2724 |
| Autores: | Madeira, Luciana da Silva1 Borschiver, Suzana2 Pereira-Junior, Nei2 |
| Instituciones: | 1Fundacao Oswaldo Cruz, Instituto de Tecnologia em Imunobiológicos, Manguinhos, Rio de Janeiro. Brasil 2Universidade Federal do Rio de Janeiro, Escola de Quimica, Rio de Janeiro. Brasil |
| Año: | 2012 |
| Periodo: | Oct |
| Volumen: | 7 |
| Número: | 3 |
| Paginación: | 44-56 |
| País: | Chile |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Analítico, descriptivo |
| Resumen en inglés | The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selected because they are not produced in Brazil and thus could increase the technological capacity of domestic production. The use of a data mining tool facilitated the results achieved here, using the patents deposited in several banks worldwide as the source information. The prospects and trends of producing biopharmaceuticals in Brazil are of great interest to the country to establish a competitive industry and reduce the vulnerability of the National Health System, such as display windows of opportunity, showing the possibility of moving towards the production of biopharmaceuticals |
| Disciplinas: | Administración y contaduría, Medicina |
| Palabras clave: | Administración de la producción, Farmacología, Mercadotecnia, Tendencias, Mercados, Biofarmacéutica, Patentes, Previsión, Brasil |
| Texto completo: | Texto completo (Ver HTML) |
